News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VisionGate To Present Early Lung Cancer Detection Data At American Society of Clinical Oncology


5/7/2014 8:24:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VisionGate, Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, today announced that data on sensitivity and specificity of its LuCED lung cancer detection test will be presented at the American Society of Clinical Oncology’s (ASCO) 50th annual conference at McCormick Place in Chicago. ASCO runs from May 30 to June 2.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES